IDR 2950.0
(-2.64%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 2519.46 Billion IDR | -20.32% |
2022 | 2384.21 Billion IDR | -2.57% |
2021 | 2447.15 Billion IDR | 36.89% |
2020 | 1787.72 Billion IDR | -14.12% |
2019 | 2081.69 Billion IDR | 27.68% |
2018 | 1630.33 Billion IDR | 20.4% |
2017 | 1354.13 Billion IDR | 10.04% |
2016 | 1230.55 Billion IDR | 27.48% |
2015 | 965.32 Billion IDR | 23.14% |
2014 | 783.94 Billion IDR | 35.16% |
2013 | 580.01 Billion IDR | 57.67% |
2012 | 367.86 Billion IDR | 50.11% |
2011 | 245.05 Billion IDR | 56.19% |
2010 | 156.89 Billion IDR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 758.26 Billion IDR | 44.89% |
2024 Q2 | 548.39 Billion IDR | 14.92% |
2024 Q1 | 477.2 Billion IDR | -15.45% |
2023 Q3 | 685.18 Billion IDR | 14.72% |
2023 Q2 | 597.24 Billion IDR | -4.07% |
2023 Q1 | 622.56 Billion IDR | 0.45% |
2023 FY | 1899.86 Billion IDR | -20.32% |
2023 Q4 | 564.38 Billion IDR | -17.63% |
2022 FY | 2384.21 Billion IDR | -2.57% |
2022 Q4 | 619.78 Billion IDR | -0.57% |
2022 Q3 | 623.33 Billion IDR | 12.49% |
2022 Q2 | 554.14 Billion IDR | -5.59% |
2022 Q1 | 586.94 Billion IDR | 6.68% |
2021 Q4 | 550.21 Billion IDR | -10.49% |
2021 Q2 | 701.69 Billion IDR | 20.86% |
2021 Q3 | 614.67 Billion IDR | -12.4% |
2021 FY | 2447.15 Billion IDR | 36.89% |
2021 Q1 | 580.57 Billion IDR | 28.17% |
2020 FY | 1787.72 Billion IDR | -14.12% |
2020 Q2 | 409.13 Billion IDR | -17.53% |
2020 Q1 | 496.09 Billion IDR | -28.15% |
2020 Q4 | 452.95 Billion IDR | 5.45% |
2020 Q3 | 429.54 Billion IDR | 4.99% |
2019 FY | 2081.69 Billion IDR | 27.68% |
2019 Q3 | 470.96 Billion IDR | 2.37% |
2019 Q2 | 460.05 Billion IDR | -0.04% |
2019 Q4 | 690.41 Billion IDR | 46.6% |
2019 Q1 | 460.25 Billion IDR | 7.77% |
2018 Q3 | 421.75 Billion IDR | 7.51% |
2018 Q4 | 427.09 Billion IDR | 1.27% |
2018 FY | 1630.33 Billion IDR | 20.4% |
2018 Q1 | 389.2 Billion IDR | 10.49% |
2018 Q2 | 392.29 Billion IDR | 0.79% |
2017 FY | 1354.13 Billion IDR | 10.04% |
2017 Q3 | 348.33 Billion IDR | 2.05% |
2017 Q1 | 312.19 Billion IDR | -3.12% |
2017 Q4 | 352.25 Billion IDR | 1.13% |
2017 Q2 | 341.35 Billion IDR | 9.34% |
2016 Q3 | 300.69 Billion IDR | -4.32% |
2016 FY | 1230.55 Billion IDR | 27.48% |
2016 Q2 | 314.25 Billion IDR | 7.12% |
2016 Q1 | 293.35 Billion IDR | 8.39% |
2016 Q4 | 322.24 Billion IDR | 7.17% |
2015 Q1 | 232.08 Billion IDR | 0.76% |
2015 Q2 | 197.42 Billion IDR | -14.93% |
2015 FY | 965.32 Billion IDR | 23.14% |
2015 Q4 | 270.65 Billion IDR | 2.08% |
2015 Q3 | 265.15 Billion IDR | 34.3% |
2014 Q3 | 202 Billion IDR | 8.81% |
2014 Q2 | 185.65 Billion IDR | 11.86% |
2014 Q1 | 165.96 Billion IDR | 4.3% |
2014 FY | 783.94 Billion IDR | 35.16% |
2014 Q4 | 230.32 Billion IDR | 14.02% |
2013 Q4 | 159.13 Billion IDR | 9.84% |
2013 Q1 | 121.71 Billion IDR | 8.86% |
2013 FY | 580.01 Billion IDR | 57.67% |
2013 Q2 | 154.28 Billion IDR | 26.76% |
2013 Q3 | 144.88 Billion IDR | -6.09% |
2012 Q4 | 111.8 Billion IDR | 0.0% |
2012 FY | 367.86 Billion IDR | 50.11% |
2011 FY | 245.05 Billion IDR | 56.19% |
2010 FY | 156.89 Billion IDR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
PT Bundamedik Tbk | 463.16 Billion IDR | -443.961% |
PT Metro Healthcare Indonesia Tbk | 125.19 Billion IDR | -1912.446% |
PT Medikaloka Hermina Tbk | 1043.54 Billion IDR | -141.434% |
PT Mitra Keluarga Karyasehat Tbk | 783.59 Billion IDR | -221.527% |
PT Murni Sadar Tbk | 224.61 Billion IDR | -1021.698% |
PT Famon Awal Bros Sedaya Tbk | 293.68 Billion IDR | -757.893% |
PT Royal Prima Tbk | 75.23 Billion IDR | -3248.726% |
PT Kedoya Adyaraya Tbk | 105.27 Billion IDR | -2293.327% |
PT Sarana Meditama Metropolitan Tbk | 393.56 Billion IDR | -540.167% |
PT Sejahteraraya Anugrahjaya Tbk | 583.07 Billion IDR | -332.102% |